Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
Schiano
T D
TD
Department of Medicine, University of Chicago Medical Center, Illinois 60637, USA.
Lissoos
T W
TW
Ahmed
A
A
Siano
C
C
Zaitman
D
D
Cohn
G
G
Ehrenpreis
E D
ED
D000368:Aged; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001201:Ascites / Q000139:chemically induced; D004338:Drug Combinations; D015658:HIV Infections / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy; D006521:Hepatitis, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D019259:Lamivudine / Q000008:administration & dosage / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000821:virology*; D017093:Liver Failure / Q000139:chemically induced*; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D018119:Stavudine / Q000008:administration & dosage / Q000009:adverse effects*
D019380:Anti-HIV Agents; D004338:Drug Combinations; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D018119:Stavudine